Serve : Enjoy your homemade glutathione-rich drink as a refreshing, daily boost for your skin
In October, at the American College of Rheumatology Convergence 2025, interim Phase 1b results for SBT777101, an autologous CAR regulatory T-cell therapy, showed early signs of clinical activity and a favorable safety profile with no dose-limiting toxicities, cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome
Patients should not consider allulose a substitute for prescribed GLP-1 agonist medications or expect comparable therapeutic effects for diabetes management or weight loss
Los resultados del estudio en fase1 en humanos muestran prdidas de peso del 14% en 30das con descensos en glucosa, glucagn y protena C reactiva y un perfil de seguridad aceptable48
Nearly 12% of Americans have used GLP-1s for weight loss alone, while many others rely on them to treat conditions such as Type 2 diabetes
Lowering this oxidative burden in the scalp could indirectly reduce stress on androgensensitive follicles and limit redoxdriven amplification of androgen pathways, even though it does not block hormones or 5alpha reductase in the same way as systemic drugs